CDC/Health Resources and Services Administration (HRSA) Advisory Committee on HIV and STD Prevention and Treatment

---
identifier: "/us/fr/E9-8071"
source: "fr"
legal_status: "authoritative_unofficial"
title: "CDC/Health Resources and Services Administration (HRSA) Advisory Committee on HIV and STD Prevention and Treatment"
title_number: 0
title_name: "Federal Register"
section_number: "E9-8071"
section_name: "CDC/Health Resources and Services Administration (HRSA) Advisory Committee on HIV and STD Prevention and Treatment"
positive_law: false
currency: "2009-04-09"
last_updated: "2009-04-09"
format_version: "1.1.0"
generator: "[email protected]"
agency: "Health and Human Services Department"
document_number: "E9-8071"
document_type: "notice"
publication_date: "2009-04-09"
agencies:
  - "Health and Human Services Department"
  - "Centers for Disease Control and Prevention"
fr_citation: "74 FR 16212"
fr_volume: 74
---


#  CDC/Health Resources and Services Administration (HRSA) Advisory Committee on HIV and STD Prevention and Treatment

In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), the CDC announces  the following meeting of the aforementioned committee:

*Times and Dates:*

8 a.m.-5 p.m., May 19, 2009

8 a.m.-3 p.m., May 20, 2009

*Place:* JW Marriott Buckhead, 3300 Lenox Road, Atlanta, Georgia 30326, *Telephone:* (404) 262-3344, *Fax:* (404) 262-8689.

*Status:* Open to the public, limited only by the space available. The meeting room will accommodate approximately 100 people.

*Purpose:* This Committee is charged with advising the Director, CDC and the Administrator, HRSA, regarding activities related to prevention and control of HIV/AIDS and other STDs; the support of health care services to persons living with HIV/AIDS; and education of health professionals and the public about HIV/AIDS and other STDs.

*Matters To Be Discussed:* Agenda items include issues pertaining to: (1) Updates on HIV Testing, Syphilis Elimination and Viral Hepatitis Prevention; (2) Preventing HIV, STD, Hepatitis and TB in Correctional Settings; (3) Update on HIV Surveillance; and (4) Challenges and Opportunities to STD Prevention. Agenda items are subject to change as priorities dictate.

*Contact Person for More Information:* Margie Scott-Cseh, Committee Management Specialist, CDC, Strategic Business Unit, 1600 Clifton Road, NE., Mailstop E-07, Atlanta, Georgia 30333, *Telephone:* (404) 639-8317, *Fax:* (404) 639-8600, *E-mail:**[email protected]* .

The Director, Management Analysis and Services Office, has been delegated the authority to sign *Federal Register* Notices pertaining to announcements of meetings and other committee management activities, for both the CDC and the Agency for Toxic Substances and Disease Registry.

Dated: April 3, 2009.

Elaine L. Baker,

Director, Management Analysis and Services Office, Centers for Disease Control and Prevention.